Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
View on Grants.gov ↗ Sign in to save
- Type
- Grant forecast
- Notice type
- G
- Agency
- Food and Drug Administration
- Sub-agency
- HHS-FDA
- Solicitation #
- FOR-FD-25-020
- Posted
- Jul 11, 2025
- CFDA / Assistance listing
- 93.103
- Contact
- Kimberly Pendleton · Kimberly.Pendleton@fda.hhs.gov · 240-402-7610
- Source
- Grants.gov
Description
The purpose of this opportunity is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.